Acne vulgaris

For treatment of acne in children over 12 years, refer to the adult pathways below.

NICE NG198: Acne vulgaris Dermatology Pathways: Acne BAD Patient Information: Acne

Treatment of mild to moderate acne vulgaris

See prescribing notes for additional guidance.


Benzoyl peroxide + Clindamycin
Benzoyl peroxide 3% / Clindamycin 1% gel
Benzoyl peroxide 5% / Clindamycin 1% gel
Clindamycin + Tretinoin
Treclin 1%/0.025% gel
Adapalene + Benzoyl peroxide
Adapalene 0.1% / Benzoyl peroxide 2.5% gel
Adapalene 0.3% / Benzoyl peroxide 2.5% gel

Alternative monotherapy if first line options are contraindicated, or person wishes to avoid using a topical retinoid or antibiotic.

Benzoyl peroxide
Benzoyl peroxide 5% gel

Alternative monotherapy if other options are contraindicated.


Adapalene
Adapalene 0.1% gel
Adapalene 0.1% cream
Trifarotene
Trifarotene 50micrograms/g cream

Alternative for patients with contraindications to other options or who wish to avoid topical retinoids.

Erythromycin + Zinc acetate
Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion

Prescribing Notes:

  • Tetracyclines and retinoids (systemic or topical) must be avoided in pregnancy. Females of childbearing age must use effective contraception when using topical retinoids and related drugs including: adapalene, trifarotene and Treclin gel.

History Notes

27/05/2026

Regional formulary chapter launched.

Treatment of moderate to severe acne vulgaris

Topical adapalene with benzoyl peroxide, plus an oral antibiotic (see below).

Adapalene + Benzoyl peroxide
Adapalene 0.1% / Benzoyl peroxide 2.5% gel
Adapalene 0.3% / Benzoyl peroxide 2.5% gel

Oral doxycycline is the preferred antibiotic. Lymecycline should only be used if there are issues with doxycycline (e.g. photosensitivity). Erythromycin can be used if contraindications/intolerances to tetracyclines.

Doxycycline
Doxycycline 100mg capsules
Lymecycline
Lymecycline 408mg capsules
Erythromycin
Erythromycin 250mg gastro-resistant tablets

Topical azelaic acid, plus an oral antibiotic (see below).

Azelaic acid
Azelaic acid 20% cream
Azelaic acid 15% gel

Oral doxycycline is the preferred antibiotic. Lymecycline should only be used if there are issues with doxycycline (e.g. photosensitivity). Erythromycin can be used if contraindications/intolerances to tetracyclines.

Doxycycline
Doxycycline 100mg capsules
Lymecycline
Lymecycline 408mg capsules
Erythromycin
Erythromycin 250mg gastro-resistant tablets

For females in the treatment of moderate to severe acne, vulgaris if the chosen first-line treatment is not effective, consider adding co-cyprindiol or an alternative combined oral contraceptive pill.

Co-cyprindiol
Co-cyprindiol 2000microgram/35microgram tablets

Spironolactone can be considered in moderate to severe acne vulgaris in women who have failed to respond/not tolerate one topical and one systemic agent as above. It can be used as monotherapy or in addition to the options above.

Spironolactone
Spironolactone 50mg tablets
Spironolactone 100mg tablets

Prescribing Notes:

  • Do not use systemic monotherapy with a topical antibiotic, monotherapy with an oral antibiotic or topical and oral antibiotics in combination.
  • Evidence suggests there is limited clinical benefit in using antibiotics for >3 months.
  • Prolonged antibiotic exposure increases risk of resistance in pathogenic bacteria.
  • Antibiotics should not be continued beyond 6 months unless in exceptional circumstances on advice of dermatologist.
  • Tetracyclines and retinoids (systemic or topical) must be avoided in pregnancy. Females of childbearing age must use effective contraception when using topical retinoids and related drugs including: adapalene, trifarotene, and Treclin gel.
  • Co-cyprindiol is a treatment for moderate to severe acne vulgaris where other treatments have failed and only in those patients may it also be used as an oral contraceptive. Co-cyprindiol should be withdrawn 3-4 cycles after the treated condition has completely resolved. If ongoing contraception is required, substitution with another combined oral contraceptive is likely to maintain the improvement.

History Notes

27/05/2026

Regional formulary chapter launched.

Treatment of severe acne vulgaris (specialist use only treatment)

Consider in people older than 12 years who have a severe form of acne vulgaris that is resistant to adequate courses of standard therapy with systemic antibiotics and topical therapy.

Isotretinoin
Isotretinoin 5mg capsules
Isotretinoin 10mg capsules
Isotretinoin 20mg capsules

Prescribing Notes:

History Notes

27/05/2026

Regional formulary chapter launched.

Child under 12 years: Treatment of mild to moderate acne vulgaris

Combination product for the treatment of mild acne vulgaris that is mostly inflammatory in nature. Adapalene + Benzoyl peroxide gel is licensed for children aged 9 years and over.

Adapalene + Benzoyl peroxide
Adapalene 0.1% / Benzoyl peroxide 2.5% gel

Used in combination for the treatment of mild acne that is mostly inflammatory in nature.

Benzoyl peroxide
Benzoyl peroxide 5% gel
Clindamycin
Clindamycin 1% aqueous lotion

Alternative monotherapy if first and second-line options are contraindicated, or person wishes to avoid using a topical retinoid or antibiotic.

Benzoyl peroxide
Benzoyl peroxide 5% gel

Alternative for patients with contraindications to other options or who wish to avoid topical retinoids.

Erythromycin + Zinc acetate
Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion

Prescribing Notes:

  • Tetracyclines and retinoids (systemic or topical) must be avoided in pregnancy. Females of childbearing age must use effective contraception when using topical retinoids and related drugs including: adapalene, trifarotene and Treclin gel.

History Notes

27/05/2026

Regional formulary chapter launched.

Child under 12 years: Treatment of moderate to severe acne vulgaris

Topical adapalene with benzoyl peroxide, plus an oral antibiotic.


Adapalene + Benzoyl peroxide gel is licensed for children aged 9 years and over.

Adapalene + Benzoyl peroxide
Adapalene 0.1% / Benzoyl peroxide 2.5% gel

Erythromycin or trimethoprim. Note that liquid formulations are less cost-effective than tablets.

Erythromycin
Erythromycin 250mg gastro-resistant tablets
Erythromycin ethyl succinate 250mg/5ml oral suspension sugar free
Trimethoprim
Trimethoprim 100mg tablets
Trimethoprim 200mg tablets
Trimethoprim 50mg/5ml oral suspension sugar free

Specialist recommendation when adapalene 0.1%/benzoyl peroxide 2.5% gel not suitable. May be less irritating.

Azelaic acid
Azelaic acid 20% cream
Azelaic acid 15% gel

Erythromycin or trimethoprim. Note that liquid formulations are less cost-effective than tablets.

Erythromycin
Erythromycin 250mg gastro-resistant tablets
Erythromycin ethyl succinate 250mg/5ml oral suspension sugar free
Trimethoprim
Trimethoprim 100mg tablets
Trimethoprim 200mg tablets
Trimethoprim 50mg/5ml oral suspension sugar free

Prescribing Notes:

  • Tetracyclines and retinoids (systemic or topical) must be avoided in pregnancy. Females of childbearing age must use effective contraception when using topical retinoids and related drugs including: adapalene, trifarotene and Treclin gel.
  • Do not use systemic monotherapy with a topical antibiotic, monotherapy with an oral antibiotic or topical and oral antibiotics in combination.

History Notes

27/05/2026

Regional formulary chapter launched.

Child under 12 years: Treatment of severe acne vulgaris (specialist use only treatment)

Consider in children under 12 years who have a severe form of acne vulgaris that is resistant to adequate courses of standard therapy with systemic antibiotics and topical therapy.

Isotretinoin
Isotretinoin 5mg capsules
Isotretinoin 10mg capsules
Isotretinoin 20mg capsules

Prescribing Notes:

  • Oral isotretinoin is a toxic and teratogenic drug. Isotretinoin should be dispensed by a hospital-based pharmacy. Prescription of systemic isotretinoin for women is only possible if adequate contraception is undertaken (Pregnancy prevention programme).
  • See MHRA Drug Safety Update (October 2023) ‘Isotretinoin (Roaccutane): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age’ and manufacturer’s risk minimisation materials.
  • Further information also available at BAD Isotretinoin Clinical Resources.

History Notes

27/05/2026

Regional formulary chapter launched.